espa
 

Τι πρέπει να γνωρίζω

Μάθετε για τις χρήσεις των βλαστοκυττάρων

 

Ενημερωτικό Υλικό

Μάθετε για τις χρήσεις των βλαστοκυττάρων

 

Κλείστε ραντεβού εδώ

Ενημερωθείτε υπεύθυνα για τα βλαστοκύτταρα

Biohellenika follows a specific certified method. Furthermore Biohellenika uses special material and reagents certified from the relevant organizations (FDA, EC.) IVD and for human use. The process of the stem cells isolation and cryopreservation is performed in a closed system (sterile), so the cells do not come in contact with the environment. Only specified from ΕΟΦ materials are used and prior to the storage the process of exclusion of the red blood cell from the finale volume of storage is performed.

The results of the exclusion of the red blood cells are certified with tests that are performed with a hematology analytic device and a flow cytometer at the beginning and the end of the process. For the count of the hemopoetic stem cells of the sample a package of reactants designated for clinical use from the European Union is used.

The storage of the stem cells can be performed in cryovials or cryobags. For the storage to be performed in cryovials a small volume of cryopreservation is required that is reached with full exclusion of the red blood cells from the initial collection volume. The cryovials are stored in liquid nitrogen were the temperature is preserved stable at -196°C during the whole duration of the storage of the cells. The storage in cryovials gives the possibility of storage in two separate locations and thus rises the safely of the sample in cases of natural disasters and provides the possibility for more than one uses without defrosting and refreezing of the whole sample.

The storage in sacs is preferred mainly by the public bank were the stem cells are used one time only and only for the treatment of diseases of the blood. Due to the fact that a large number of red blood cells remain in the sample the donor and the patient must have the same blood type and so within the family they can be used only by members that share the same blood type. The sacs are stored only in liquid nitrogen steams due to the problem of fragility that they present were the temperature fluctuated and for this reason the public bank recycles its samples every 5 years. The preservation in sacs does not require a specially trained staff, it is a simplified method and is addressed more to the public storage and for the use in diseases of the hemopoetic system and is not recommended for applications of regenerative medicine that are considered treatments of the future.

Scientists have observed the sacs of cryopreservation that are defrosted for transplantation in a public bank in the United States as to their credibility from January 2000 until May 2006. At the same time they recorded the results of the transplantations after the administration of the samples that came from sacs that were ruptured, at the cases were the doctors decided to administer the sample ignoring this fact. The results showed that the 3,5% up to 9,6% presented signs of rupture. Most of the ruptures (75%) were found in sacs that had been cryopreserved for more than 2 years. In spite of the increased administration of antibiotics no other serious side effect was observed.

Biohellenika has the know-how and the special equipment of the storage either in cryobags or cryovials. After carefully informing the parents, it follows the way of storage that they have selected.

The process in Biohellenika is performed with the special device ΑΧΡ Autoexpress Platfrom of Thermogenesis USA, the only in Europe that results in 98% retrieval of the whole quantity of the stem cells of the initial sample.

In cases of a large initial sample Biohellenika after consultation with the parents can store the stem cells in two cryobags to assure storage in two different locations.

The containers were the samples are stored are equipped with an automatic system of liquid nitrogen intake and therefore remain always full and there is never danger of damage in the level of the liquid nitrogen falls.

Furthermore in Biohellenika the containers are checked on a 24 hour base for the level and the temperature of the surface with a special surveillance and alarm system. The company has also two generators of electric current (main and spare).

Awards

The scientific work of Biohellenika’s scientists’ team is internationally recognized having received Awards and Commendations




image2

22o

Award- 22nd Northern-Greece medical congress, Thessaloniki Medical Society


image2

Second award- Athens Medical Society


image2

Commendation-Hellenic Transplants’ Society

Current Stem Cell Applications

  • Bone Marrow Failure Disorders

Amegakaryocytosis

Aplastic Anemia (Severe)

Blackfan-Diamond Anemia

Congenital Cytopenia*

Congenital Dyserythropoietic Anemia

Dyskeratosis Congenita

Fanconi Anemia

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Pure Red Cell Aplasia

  • Hemoblobinopathies

Beta Thalassemia Major

Sickle Cell Disease

  • Histiocytic Disorders

Familial Erythrophagocytic Lymphohistiocytosis

Hemophagocytosis

Langerhans Cell Histiocytosis (Histiocytosis X)

  • Inherited Immune System Disorders

Chronic Granulomatous Disease

Congenital Neutropenia

Leukocyte Adhesion Deficiency

Severe Combined Immunodeficiencies (SCID) including:

Adenosine Deaminase Deficiency*

Bare Lymphocyte Syndrome

Chediak-Higashi Syndrome*

Kostmann Syndrome

Omenn Syndrome

Purine Nucleoside Phosphorylase Deficiency

Reticular Dysgenesis

Wiskott-Aldrich Syndrome

X-Linked Lymphoproliferative Disorder

  • Inherited Metabolic Disorders

Adrenoleukodystrophy

Fucosidosis

Gaucher Disease*

Hunter Syndrome (MPS-II)

Hurler Syndrome (MPS-IH)

Krabbe Disease

Lesch-Nyhan Syndrome

Mannosidosis*

Maroteaux-Lamy Syndrome (MPS-VI)

Metachromatic Leukodystrophy

Mucolipidosis II (I-cell Disease)*

Neuronal Ceroid Lipofuscinosis (Batten Disease)*

Niemann-Pick Disease*

Sandhoff Disease*

Sanfilippo Syndrome (MPS-III)

Scheie Syndrome (MPS-IS)

Sly Syndrome

Tay Sachs*

Wolman Disease

  • Leukemias and Lymphomas

Acute Biphenotypic Leukemia*

Acute Lymphocytic Leukemia (ALL)

Acute Myelogenous Leukemia (AML)

Acute Undifferentiated Leukemia*

Adult T Cell Leukemia/Lymphoma

Chronic Lymphocytic Leukemia (CLL)

Chronic Myelogenous Leukemia (CML)

Hodgkins Lymphoma

Juvenile Chronic Myelogenous Leukemia (JCML)

Juvenile Myelomonocytic Leukemia (JMML)

Myeloid/Natural Killer (NK) Cell Precursor Acute Leukemia

Non-Hodgkins Lymphoma

Polymphocytic Leukemia

  • Myelodysplastic/Myeloproliferative Disorders

Acute Myelofibrosis*

Agnogenic Myeloid Metaplasia (Myelofibrosis)*

Amyloidosis

Chronic Myelomonocytic Leukemia (CMML)

Essential Thrombocythemia*

Polycythemia Vera*

Refractory Anemias (RA) including:

Refractory Anemia with Excess Blasts (RAEB)

Refractory Anemia with Excess Blasts in Transformation (RAEB-T)

Refractory Anemia with Ringed Sideroblasts (RARS)

  • Plasma Cell Disorders

Multiple Myeloma

Plasma Cell Leukemia

Waldenstroms Macroglobulinemia

Other Inherited Disorders

Cartilage-Hair Hypoplasia

Congenital Erythropoietic Porphyria (Gunther Disease)

DiGeorge Syndrome 

Osteopetrosis

  • Other Malignancies

Brain Tumors**

Ewing Sarcoma*

Neuroblastoma

Ovarian Cancer*

Renal Cell Carcinoma*

Rhabdomyosarcoma

Small Cell Lung Cancer*

Testicular Cancer*

Thymoma (Thymic Carcinoma)

  • Other

Chronic Active Epstein Barr

Evans Syndrome

Multiple Sclerosis*

Rheumatoid Arthritis*

Systemic Lupus Erythematosus*

Thymic Dysplasia

* in clinical trials,  www. clinicaltrials.gov

Emerging Stem Cell Applications

Diabetes

Heart Disease

Liver Disease

Muscular Dystrophy

Parkinsons Disease

Spinal cord injury

Stroke

 

Our Laboratories

-

 

Stem Cells

-

 

 

Biohellenika TV

-

 

Biohellenika Procedure

-

 

Our Brochures

-

Stem Cells Bank Biohellenika - Web design Hexabit - W3C - Pagespeed